Seeing Is Believing
Currently out of the existing stock ratings of David Hoang, 65 are a BUY (77.38%), 14 are a HOLD (16.67%), 5 are a SELL (5.95%).
Analyst David Hoang, currently employed at DEUTSCHE BANK, carries an average stock price target met ratio of 55.79% that have a potential upside of 34.25% achieved within 231 days.
David Hoang’s has documented 159 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AXSM, Axsome Therapeutics at 29-Sep-2026.
Analyst best performing recommendations are on APGE (APOGEE THERAPEUTICS).
The best stock recommendation documented was for APGE (APOGEE THERAPEUTICS) at 6/3/2026. The price target of $116 was fulfilled within 19 days with a profit of $31.81 (37.78%) receiving and performance score of 19.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Mar-2021
$16
$-0.7 (-4.19%)
$22
3 years 25 days ago
(05-Oct-2023)
1/4 (25%)
$0.05 (0.31%)
1
Buy Since 14-Sep-2020
$34
$17.3 (103.59%)
$34
3 years 2 months 21 days ago
(09-Aug-2023)
0/4 (0%)
$28.94 (571.94%)
Buy Since 29-Dec-2021
$15
$-1.7 (-10.18%)
$15
3 years 4 months 2 days ago
(27-Jun-2023)
3/3 (100%)
$9.77 (186.81%)
107
Buy Since 18-Jul-2022
$37
$20.3 (121.56%)
$50
3 years 7 months 17 days ago
(13-Mar-2023)
0/2 (0%)
$32.05 (647.47%)
Buy Since 05-Sep-2019
$13
4 years 5 months 16 days ago
(13-May-2022)
2/2 (100%)
$-34.2 (-72.46%)
621
Which stock is David Hoang most bullish on?
Which stock is David Hoang most reserved on?
What Year was the first public recommendation made by David Hoang?